SG10201507488RA - Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance - Google Patents
Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistanceInfo
- Publication number
- SG10201507488RA SG10201507488RA SG10201507488RA SG10201507488RA SG10201507488RA SG 10201507488R A SG10201507488R A SG 10201507488RA SG 10201507488R A SG10201507488R A SG 10201507488RA SG 10201507488R A SG10201507488R A SG 10201507488RA SG 10201507488R A SG10201507488R A SG 10201507488RA
- Authority
- SG
- Singapore
- Prior art keywords
- complications
- diabetes
- prevention
- type
- insulin resistance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07104624 | 2007-03-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201507488RA true SG10201507488RA (en) | 2015-10-29 |
Family
ID=38328657
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012019618A SG193655A1 (en) | 2007-03-21 | 2008-03-21 | Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance |
| SG10201507488RA SG10201507488RA (en) | 2007-03-21 | 2008-03-21 | Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012019618A SG193655A1 (en) | 2007-03-21 | 2008-03-21 | Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8389574B2 (en) |
| EP (1) | EP2136798B1 (en) |
| JP (2) | JP5982091B2 (en) |
| KR (1) | KR20090120503A (en) |
| CN (1) | CN101663030B (en) |
| AU (1) | AU2008228192B2 (en) |
| BR (1) | BRPI0809034A8 (en) |
| CA (1) | CA2681185C (en) |
| CY (1) | CY1116872T1 (en) |
| DK (1) | DK2136798T3 (en) |
| EA (1) | EA018442B1 (en) |
| ES (1) | ES2546619T3 (en) |
| HK (1) | HK1139040A1 (en) |
| HR (1) | HRP20150936T1 (en) |
| HU (1) | HUE025394T2 (en) |
| IL (1) | IL201014A (en) |
| MX (1) | MX2009009966A (en) |
| MY (1) | MY151623A (en) |
| NZ (1) | NZ579767A (en) |
| PL (1) | PL2136798T3 (en) |
| PT (1) | PT2136798E (en) |
| SG (2) | SG193655A1 (en) |
| SI (1) | SI2136798T1 (en) |
| WO (1) | WO2008113862A2 (en) |
| ZA (1) | ZA200907280B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8589106B2 (en) * | 2010-12-22 | 2013-11-19 | Roche Diagnostics Operations, Inc. | Calibration of a handheld diabetes managing device that receives data from a continuous glucose monitor |
| KR20190043076A (en) * | 2017-10-17 | 2019-04-25 | 한미약품 주식회사 | Pharmaceutical composition comprising amlodipine, losartan and rosuvastatin for prevention and treatment of cardiovascular diseases accompanied by diabetes and formulated combination including the same |
| CN115068451A (en) * | 2021-03-15 | 2022-09-20 | 中国医学科学院药物研究所 | Medical application of hypocrellin compound as LTB4 receptor inhibitor |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670827C3 (en) * | 1967-03-20 | 1974-10-24 | Bayer Ag, 5090 Leverkusen | 4- (2'-nitrophenyl) -2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridine |
| IT1254314B (en) * | 1992-03-27 | 1995-09-14 | Sigma Tau Ind Farmaceuti | PHARMACEUTICAL COMPOSITIONS CONTAINING L-CARNITINE AND ACYL-CARNITINE ASSOCIATION WITH ACE-INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES. |
| IT1263004B (en) * | 1992-10-08 | 1996-07-23 | Sigma Tau Ind Farmaceuti | USE OF L-CARNITINE AND ACIL L-CARNITINE IN THE LONG-TERM TREATMENT OF NON-INSULIN-EMPLOYEE DIABETIC PATIENTS. |
| US5925656A (en) * | 1995-04-10 | 1999-07-20 | Dr. Reddy's Research Foundation | Compounds having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| IT1290801B1 (en) * | 1996-07-05 | 1998-12-11 | Mendes Srl | USE OF ACETYL L-CARNITINE, ISOVALERYL L-CARNITINE, PROPIONYL L-CARNITINE OR THEIR PHARMACOLOGICALLY ACCEPTABLE SALTS |
| IT1293067B1 (en) * | 1997-07-01 | 1999-02-11 | Sigma Tau Ind Farmaceuti | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PATHOLOGIES CAUSED BY ALTERED LIPID METABOLISM |
| IT1291113B1 (en) * | 1997-03-20 | 1998-12-29 | Sigma Tau Ind Farmaceuti | NUTRITIONAL THERAPEUTIC COMPOSITION FOR SUBJECTS WITH DIABETES MELLITUS |
| US6281234B1 (en) * | 1998-05-12 | 2001-08-28 | American Home Products Corporation | (2-Acylaminothiazole-4-yl)acetic acid derivative |
| IT1302289B1 (en) * | 1998-09-30 | 2000-09-05 | Univ Catania | PHARMACEUTICAL COMPOSITIONS WITH ANTINEOPLASTIC ACTIVITY |
| CA2375378C (en) * | 1999-06-08 | 2009-08-11 | Arduino Arduini | Antilipemic combinations comprising hmg-coa reductase inhibitors and carnitines |
| ITRM20010294A1 (en) * | 2001-05-29 | 2002-11-29 | Sigma Tau Ind Farmaceuti | USE OF ACETYL L-CARNETINE IN ASSOCIATION WITH BIOTIN FOR THE TREATMENT OF PATIENTS WITH DIABETES TYPE II INSULIN RE |
| US20030068391A1 (en) * | 2001-10-04 | 2003-04-10 | Harris Dennis H. | Ingestible nerve and circulatory nutritional formulation |
-
2008
- 2008-03-21 PT PT87181418T patent/PT2136798E/en unknown
- 2008-03-21 CA CA2681185A patent/CA2681185C/en not_active Expired - Fee Related
- 2008-03-21 SG SG2012019618A patent/SG193655A1/en unknown
- 2008-03-21 EA EA200970877A patent/EA018442B1/en not_active IP Right Cessation
- 2008-03-21 PL PL08718141T patent/PL2136798T3/en unknown
- 2008-03-21 EP EP08718141.8A patent/EP2136798B1/en active Active
- 2008-03-21 AU AU2008228192A patent/AU2008228192B2/en not_active Ceased
- 2008-03-21 MY MYPI20094017 patent/MY151623A/en unknown
- 2008-03-21 MX MX2009009966A patent/MX2009009966A/en active IP Right Grant
- 2008-03-21 DK DK08718141.8T patent/DK2136798T3/en active
- 2008-03-21 SI SI200831494T patent/SI2136798T1/en unknown
- 2008-03-21 SG SG10201507488RA patent/SG10201507488RA/en unknown
- 2008-03-21 US US12/532,379 patent/US8389574B2/en not_active Expired - Fee Related
- 2008-03-21 CN CN200880012860XA patent/CN101663030B/en not_active Expired - Fee Related
- 2008-03-21 BR BRPI0809034A patent/BRPI0809034A8/en not_active Application Discontinuation
- 2008-03-21 WO PCT/EP2008/053437 patent/WO2008113862A2/en active Application Filing
- 2008-03-21 KR KR1020097020878A patent/KR20090120503A/en not_active Application Discontinuation
- 2008-03-21 JP JP2010500241A patent/JP5982091B2/en not_active Expired - Fee Related
- 2008-03-21 NZ NZ579767A patent/NZ579767A/en not_active IP Right Cessation
- 2008-03-21 ES ES08718141.8T patent/ES2546619T3/en active Active
- 2008-03-21 HU HUE08718141A patent/HUE025394T2/en unknown
-
2009
- 2009-09-17 IL IL201014A patent/IL201014A/en active IP Right Grant
- 2009-10-19 ZA ZA200907280A patent/ZA200907280B/en unknown
-
2010
- 2010-05-14 HK HK10104708.3A patent/HK1139040A1/en not_active IP Right Cessation
-
2014
- 2014-09-04 JP JP2014180519A patent/JP5974056B2/en not_active Expired - Fee Related
-
2015
- 2015-09-07 HR HRP20150936TT patent/HRP20150936T1/en unknown
- 2015-09-11 CY CY20151100793T patent/CY1116872T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20180667T1 (en) | A klotho-beta agonist antibody for use in the treatment of diabetes mellitus or insulin resistance | |
| IL215925A0 (en) | Electrokinetically-altered fluid compositions and use thereof for treating insulin resistance and diabetes mellitus | |
| IL195947A (en) | Fused cyclic compounds and pharmaceutical compositions comprising them for use in the prevention and treatment of diabetes | |
| EP2022495A4 (en) | Composition for preventing the occurrence of cardiovascular event in multiple risk patient | |
| EP2070540A4 (en) | Drug composition for treating 2 type diabetes and its chronicity neopathy | |
| IL184312A0 (en) | Herbal compositions for the treatment of diabetes and/or conditions associated therewith | |
| EP2307544A4 (en) | Genetic component of complications in type 2 diabetes | |
| ZA201000990B (en) | Herbal formulations for controlling blood glucose levels in patients with diabetes | |
| EP2199295A4 (en) | Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome | |
| EP2298365A4 (en) | Medical composition and medical kit | |
| IL208463A (en) | 2-heterocyclyl-fused pyrrole compounds, pharmaceutical compositions comprising them and their use in the prophylaxis or treatment of diabetes or obesity | |
| IL177609A (en) | Use of gabaculine or its analog in the manufacture of a medicament for treating hepatocellular carcinoma | |
| PL2012805T3 (en) | Therapeutic composition and use | |
| PL2308497T3 (en) | Pharmaceutical composition with glycosaminoglycans and use thereof in the treatment of chronic ulcers | |
| ZA200907280B (en) | Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance | |
| ZA200904583B (en) | Dual composition with warming and analgesic effects | |
| ZA201005875B (en) | Use of interleukin-1 conjugates in the treatment of diabetes | |
| PL2217255T3 (en) | Use of phytoecdysones in the preparation of a composition for acting on metabolic syndrome | |
| HK1130177A1 (en) | A pharmaceutical composition for treating type ii diabetes and complications thereof | |
| EP2189163A4 (en) | A composition for treatment of diabetes mellitus and a preparation and an use thereof | |
| EP2275437A4 (en) | Polypeptide and pharmaceutical composition containing the polypeptide | |
| IL200192A0 (en) | Composition useful for the treatment of type 2 diabetes | |
| IL209088A0 (en) | Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and beta-cell dysfunction | |
| HK1153143A1 (en) | Pharmaceutical composition for the treatment of type 2 diabetes in mammals including human beings | |
| AU2007900629A0 (en) | Oral insulin composition and delivery |